16.07.2015 Views

review of literature on clinical pancreatology - The Pancreapedia

review of literature on clinical pancreatology - The Pancreapedia

review of literature on clinical pancreatology - The Pancreapedia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PANCREATIC PHYSIOLOGYSphincter <str<strong>on</strong>g>of</str<strong>on</strong>g> Oddi<strong>The</strong> most comm<strong>on</strong> functi<strong>on</strong>al disorder <str<strong>on</strong>g>of</str<strong>on</strong>g> the biliary tract and pancreas relates to the activity<str<strong>on</strong>g>of</str<strong>on</strong>g> the Sphincter <str<strong>on</strong>g>of</str<strong>on</strong>g> Oddi. <strong>The</strong> Sphincter <str<strong>on</strong>g>of</str<strong>on</strong>g> Oddi is a small smooth muscle sphincterstrategically placed at the juncti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> the bile duct, pancreatic duct, and duodenum. <strong>The</strong>sphincter c<strong>on</strong>trols flow <str<strong>on</strong>g>of</str<strong>on</strong>g> bile and pancreatic juices into the duodenum and prevents reflux <str<strong>on</strong>g>of</str<strong>on</strong>g>duodenal c<strong>on</strong>tent into the ducts. Disorder in its motility is called Sphincter <str<strong>on</strong>g>of</str<strong>on</strong>g> Oddidysfuncti<strong>on</strong>. Clinically this presents either with recurrent abdominal biliary type pain orepisodes <str<strong>on</strong>g>of</str<strong>on</strong>g> recurrent pancreatitis. Manometry may identify the motility abnormalities, themost <strong>clinical</strong>ly significant being an abnormally elevated basal pressure. <strong>The</strong> most effectivetreatment <strong>on</strong>ce an abnormal basal pressure is identified is divisi<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> the sphincter. This isassociated with good l<strong>on</strong>g-term results [126].Modulatory drugs <str<strong>on</strong>g>of</str<strong>on</strong>g> gastrointestinal (GI) motility are a possibility for use to relieve the main<strong>clinical</strong> presentati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> sphincter <str<strong>on</strong>g>of</str<strong>on</strong>g> Oddi (SO) dysfuncti<strong>on</strong>s which are not easily distinguishedfrom those occurring in high prevalence functi<strong>on</strong>al GI disorders. <strong>The</strong> aim <str<strong>on</strong>g>of</str<strong>on</strong>g> <strong>on</strong>e study was toinvestigate the effects <str<strong>on</strong>g>of</str<strong>on</strong>g> GI motility modulators including pinaverium, domperid<strong>on</strong>e,trimebutine, and tegaserod <strong>on</strong> the c<strong>on</strong>tractile activity <str<strong>on</strong>g>of</str<strong>on</strong>g> SO stimulated by carbachol in therabbit. <strong>The</strong> c<strong>on</strong>tracti<strong>on</strong> resp<strong>on</strong>ses prec<strong>on</strong>tracted by carbachol (0.1 µM) <str<strong>on</strong>g>of</str<strong>on</strong>g> in vitro rabbit SOrings were evaluated before and after the additi<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> a series c<strong>on</strong>centrati<strong>on</strong> (10 -13 to 10 -3 M) <str<strong>on</strong>g>of</str<strong>on</strong>g>pinaverium, domperid<strong>on</strong>e, trimebutine, and tegaserod. Pinaverium induced a c<strong>on</strong>centrati<strong>on</strong>dependentrelaxati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> isolated SO rings prec<strong>on</strong>tracted with carbachol (0.1 µM). Tegaseroddid not significantly effect SO motility, but domperid<strong>on</strong>e seemed to stimulate SOc<strong>on</strong>tracti<strong>on</strong>s. At low doses (10 -13 to 10 -7 M), trimebutine stimulated SO c<strong>on</strong>tracti<strong>on</strong>; however,high doses (10 -6 to 10 -3 M) <str<strong>on</strong>g>of</str<strong>on</strong>g> trimebutine inhibited SO motility. It was c<strong>on</strong>cluded thatpinaverium totally inhibits c<strong>on</strong>tracti<strong>on</strong>s induced by carbachol and tegaserod has no effect <strong>on</strong>carbachol-induced c<strong>on</strong>tracti<strong>on</strong>s. Domperid<strong>on</strong>e stimulates c<strong>on</strong>tracti<strong>on</strong>s induced by carbachol.Trimebutine could either stimulate or inhibit SO c<strong>on</strong>tracti<strong>on</strong>s depending <strong>on</strong> its dosage [127].Feeding<strong>The</strong> complex c<strong>on</strong>trol <str<strong>on</strong>g>of</str<strong>on</strong>g> food intake and energy metabolism in mammals relies <strong>on</strong> the ability<str<strong>on</strong>g>of</str<strong>on</strong>g> the brain to integrate multiple signals indicating the nutriti<strong>on</strong>al state and the energy level <str<strong>on</strong>g>of</str<strong>on</strong>g>the organism and to produce appropriate resp<strong>on</strong>ses in terms <str<strong>on</strong>g>of</str<strong>on</strong>g> food intake, energyexpenditure, and metabolic activity. Central regulati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> feeding is organized as a l<strong>on</strong>g-loopmechanism involving humoral signals and afferent neur<strong>on</strong>al pathways to the brain,processing in hypothalamic neur<strong>on</strong>al circuits, and descending commands using vagal andspinal neur<strong>on</strong>s. Sensor mechanisms or receptors sensitive to glucose and fatty acidmetabolism, neuropeptide and cannabinoid receptors, as well as neurotransmitters andneuromodulators synthesized and secreted within the brain itself are all signals integrated inthe hypothalamus, which therefore functi<strong>on</strong>s as an integrator <str<strong>on</strong>g>of</str<strong>on</strong>g> signals from central andperipheral structures. Homeostatic feedback mechanisms involving afferent neuroendocrineinputs from peripheral organs, like adipose tissue, gut, stomach, endocrine pancreas,adrenal, muscle, and liver, to hypothalamic sites thus c<strong>on</strong>tribute to the maintenance <str<strong>on</strong>g>of</str<strong>on</strong>g>normal feeding behavior and energy balance. In additi<strong>on</strong> to transcripti<strong>on</strong>al events, peripheralhorm<strong>on</strong>es may also alter firing and/or c<strong>on</strong>necti<strong>on</strong> (synaptology) <str<strong>on</strong>g>of</str<strong>on</strong>g> hypothalamic neur<strong>on</strong>alnetworks in order to modulate food intake. Moreover, intracellular energy sensing andsubsequent biochemical adaptati<strong>on</strong>s, including an increase in AMP-activated protein kinaseactivity, occur in hypothalamic neur<strong>on</strong>s. Understanding the regulati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> appetite is clearly amajor research effort but also seems promising for the development <str<strong>on</strong>g>of</str<strong>on</strong>g> novel therapeuticstrategies for obesity [128].

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!